<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="142791">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on April 10, 2017</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01241981</url>
  </required_header>
  <id_info>
    <org_study_id>2010ON15</org_study_id>
    <nct_id>NCT01241981</nct_id>
  </id_info>
  <brief_title>Digital Breast Tomosynthesis in Younger Symptomatic Women</brief_title>
  <official_title>Digital Breast Tomosynthesis (DBT): Sensitivity for Cancer and Accuracy in Assessing Extent of Malignant Disease in Symptomatic Women Below 60 With Clinical or Ultrasound Signs Compatible With Malignancy</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Liz Coote</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>University of Dundee</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>NHS Tayside</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study will examine a new imaging technique called digital breast tomosynthesis (DBT)
      compared to standard mammography in women under 60 presenting with signs of breast cancer.
      The reason that we need to do this study is that standard mammography fails to detect the
      cancer in approximately 20% of these women because younger women have denser breast tissue.
      We hope that DBT will be more sensitive in detecting breast cancer than standard
      mammography.
    </textblock>
  </brief_summary>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date>March 2011</start_date>
  <completion_date type="Anticipated">March 2013</completion_date>
  <primary_completion_date type="Anticipated">December 2012</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Sensitivity of DBT for breast cancer, compared with FFDM</measure>
    <time_frame>Two years</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Accuracy of DBT compared with FFDM in assessment of tumour extent</measure>
    <time_frame>Two years</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Relative accuracy of DBT and FFDM by breast density</measure>
    <time_frame>Two years</time_frame>
  </secondary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">200</enrollment>
  <condition>Breast Cancer</condition>
  <arm_group>
    <arm_group_label>Digital Breast Tomosynthesis</arm_group_label>
    <description>Digital Breast Tomosynthesis</description>
  </arm_group>
  <eligibility>
    <study_pop>
      <textblock>
        Women under 60 years of age with clinical or ultrasound suspicion of breast cancer
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Female

          -  Under 60 years old

          -  Clinical or ultrasound suspicion of breast cancer

        Exclusion Criteria:

          -  Unable to give informed consent

          -  Male

          -  Obvious advanced breast cancer

          -  Obvious medical problems meaning surgery would not be an option
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>59 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Andrew J Evans, FRCR</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Dundee, NHS Tayside</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Andrew J Evans, FRCR</last_name>
    <phone>+44(0)1382632196</phone>
    <email>a.z.evans@dundee.ac.uk</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Patricia J Whelehan, MSc</last_name>
    <phone>+44(0)1382496426</phone>
    <email>p.j.whelehan@dundee.ac.uk</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>NHS Tayside, Ninewells Hospital &amp; Medical School</name>
      <address>
        <city>Dundee</city>
        <state>Tayside</state>
        <zip>DD1 9SY</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Evans</last_name>
    </contact>
    <investigator>
      <last_name>Andrew Evans, FRCR</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>United Kingdom</country>
  </location_countries>
  <verification_date>October 2011</verification_date>
  <lastchanged_date>October 3, 2011</lastchanged_date>
  <firstreceived_date>November 15, 2010</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor-Investigator</responsible_party_type>
    <investigator_affiliation>NHS Tayside</investigator_affiliation>
    <investigator_full_name>Liz Coote</investigator_full_name>
    <investigator_title>R&amp;D Manager</investigator_title>
  </responsible_party>
  <keyword>Breast</keyword>
  <keyword>Cancer</keyword>
  <keyword>Digital</keyword>
  <keyword>Mammography</keyword>
  <keyword>Tomosynthesis</keyword>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
